Effects of camrelizumab combined with first-line chemotherapy on serum scc, vegf levels, and adverse reactions in patients with advanced squamous cell carcinoma of the lung

HIGHLIGHTS

• who: Chemotherapy on Serum SCC et al. from the Department of Toracic Surgery, Afliated Hospital of Qingdao University, Qingdao, China have published the research work: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung, in the Journal: Computational Intelligence and Neuroscience of 18/Nov/2022
• what: According to the results the authors compare the data of patients in both groups so as to fnd out the similarities and diferences.
• future: In the early stage of the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.